News
A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...
3h
Zacks Investment Research on MSNGILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
Shares of Gilead Sciences, Inc. (GILD) tumbled 2.2% on Aug. 21, after pharmacy benefit manager CVS Health (CVS) decided not ...
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
Is August too early to get this year’s influenza vaccine? Here’s when and where flu shots are available and when the CDC recommends getting one.
1d
Investor's Business Daily on MSNCVS Health Stock Runs Hot Once Again, Hitting A New Buy Point
CVS Health stock offers an above-average dividend yield for investors seeking income and it's run up to a new buy point.
On Tuesday, Federal Court Judge Mitchell Goldberg issued a ruling that is the second staggering decision against Woonsocket-based CVS in recent weeks. Whistleblowers brought the two cases alleging ...
Caremark was found liable in June, and Philadelphia federal court Chief Judge Mitchell Goldberg ordered the company to pay $95 million in damages, deferring final rulings on penalties.
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
With many PBMs under scrutiny, smaller startups that bill themselves as transparent are seeing interest from employers.
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results